Sector: Pharmaceuticals & Biotechnology

Mid Cap

Marksans Pharma Share Price

Marksans Pharma Ltd.

₹218.90

7.04(3.32%)

Invest in MARKSANS with up to 2.22x margin.

Trade with MTF

25th May 2026 | 10:58 AM

NSE : MARKSANS

Open Free Demat Account

Marksans Pharma Performance

Price Movement

₹218.90

₹213.97

₹220.40

↘ Today's Low↗ Today's High

1 Year Performance

₹218.90

₹155.00

₹270.70

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹220.40

Low₹213.97

Open at₹214.00

Prev Close₹211.86

Volumes9.25 L

Avg Price₹217.33

Lower Circuit₹169.49

Upper Circuit₹254.23

Historical Performance

3M High₹225.49

3M Low₹155.00

1 Yr High₹270.70

1 Yr Low₹155.00

3 Yr High₹358.70

3 Yr Low₹70.55

5 Yr High₹358.70

5 Yr Low₹38.60

Marksans Pharma Fundamentals

Market Cap

Above industry Median

9,600.70 Cr.

PE Ratio (TTM)

Above industry Median

26.60

Dividend Yield

Below industry Median

0.40

Net Profit TTM

2% decr over last year

360.32

Net Profit Growth

2% decr over last year

360.32

PEG Ratio

Negative PEG TTM

-12.30

ROE

1.5% incr over last year

15.42

Operating Revenue TTM

2,803.28

Operating Revenue Growth

13.3% incr over last year

Book Value

Above industry Median

3.40

MFI

MFI strongly Overbought

84.75

RSI

RSI Overbought

71.25

EPS (TTM)

8.40

Debt to Equity

0.01

Face Value

Operating Profit Margin Qtr.

19.63

Operating Profit Qtr.

160.74

Net Profit Qtr.

113.20

Operating Revenue Qtr.

754.43

PB Ratio

3.40

Marksans Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	339.73	320.44	319.73	299.36	311.86
Operating Expense	264.28	248.37	249.68	248.78	251.92
Operating Profit	75.44	72.08	70.05	50.57	59.94
Depreciation	8.83	8.46	8.19	8.18	7.42
Interest	0.36	0.32	0.30	0.31	0.30
Tax	21.20	21.69	15.52	12.31	19.26
Net Profit	60.91	99.81	48.06	37.59	55.46

Marksans Pharma Technicals

Marksans Pharma Ltd. EMA & SMA

₹218.90

2.73 (1.26%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹210.8

Day EMA10 ₹204.9

Day EMA12 ₹203.1

Day EMA20 ₹197.2

Day EMA26 ₹193.9

Day EMA50 ₹186.6

Day EMA100 ₹183.5

Day EMA200 ₹189.4

Marksans Pharma Support and Resistance

Resistance

First Resistance₹223.33

Second Resistance₹229.36

Third Resistance₹233.23

Support

First Support₹213.43

Second Support₹209.56

Third Support₹203.53

Technical Indicators

Day RSI71.25

Day MFI84.75

Day ADX28.98

Day Commodity Channel Index176.60

William-18.41

Day MACD9.17

Day MACD Signal Line7.24

Day ATR9.07

Day ROC12515.37

Day ROC2121.24

Marksans Pharma Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	43.9	43.9	43.9	43.9	43.9	43.9
FII	22	22.2	19.9	16.9	8.1	16.8
DII	4.2	4.5	5.5	5.3	5.9	6.5
Public	29.9	29.4	30.7	33.9	42.1	32.8

Marksans Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	11.25 L	31.76 L	35.42%
Week	10.04 L	33.19 L	30.26%
1 Month	7.92 L	23.35 L	33.90%
6 Month	4.25 L	10.22 L	41.60%

Marksans Pharma SWOT Analysis

Strengths20

Weakness5

Opportunity6

Threats0

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Results Screener: Stocks with upcoming results which are seeing positive shifts in share price

Relative Outperformance versus Industry over 1 Month

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Increasing profits every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Marksans Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
01 Aug, 2025	0.8	FINAL	01 Aug, 2025	Equity Share
17 Sep, 2024	0.6	FINAL	17 Sep, 2024	Equity Share
07 Jun, 2023	0.5	FINAL	07 Jun, 2023	Equity Share
19 Aug, 2022	0.25	FINAL		Equity Share
15 Sep, 2021	0.25	FINAL		Equity Share
22 Sep, 2020	0.1	FINAL		Equity Share
19 Sep, 2019	0.05	FINAL		Equity Share
19 Sep, 2018	0.05	FINAL		Equity Share
19 Sep, 2017	0.05	FINAL		Equity Share
22 Sep, 2016	0.12	FINAL		Equity Share

Marksans Pharma Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Rubicon Research Ltd.	Senores Pharmaceuticals Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹1,699.90	₹724.95	₹953.50	₹1,145.70	₹4,689.70	₹519.30
% Change	0.91%	7.66%	0.39%	3.13%	-0.96%	-0.14%
Revenue TTM (₹ Cr)	₹1,403.18	-	₹1,598.19	₹649.50	₹935	₹4,359.02
Net Profit TTM (₹ Cr)	₹185.12	-	₹206.20	₹115.38	₹257.90	₹255.19
PE TTM	57.20	-	78.90	43.30	43.40	31.80
1 Year Return	63.07	9.63	103.31	111.14	-2.21	-6.77
ROCE	31.54	34.78	34.76	15.60	-	11.40

Similar Stocks

BLUEJET

Blue Jet Healthcare Ltd

₹ 445.35

+0.97%

CONCORDBIO

Concord Biotech Ltd.

₹ 1156.70

+0.29%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 727.80

+2.06%

SUPRIYA

Supriya Lifescience Ltd.

₹ 783.45

+1.21%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1041.50

+0.24%

COHANCE

Cohance Lifesciences Ltd.

₹ 428.75

+2.44%

ERIS

Eris Lifesciences Ltd.

₹ 1345.10

+0.10%

SYNGENE

Syngene International Ltd.

₹ 465.80

+0.86%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 757.50

+0.24%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 226.41

+7.93%

STAR

Strides Pharma Science Ltd.

₹ 1176.60

+2.03%

GRANULES

Granules India Ltd.

₹ 760.30

+1.11%

FDC

FDC Ltd.

₹ 369.70

-0.95%

SHILPAMED

Shilpa Medicare Ltd.

₹ 510.85

+4.20%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 970.00

-3.61%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2067.00

+1.92%

SANOFI

Sanofi India Ltd.

₹ 3159.40

-0.12%

PGHL

Procter & Gamble Health Ltd.

₹ 5601.00

+0.86%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 628.00

-3.35%

FAQ's on MARKSANS

What is the current share price of Marksans Pharma Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Marksans Pharma Ltd. is ₹ 218.9 on the NSE and ₹ 218.85 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Marksans Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Marksans Pharma Ltd. is approximately ₹ 9600.7 Cr.

What are the PE and PB ratios for Marksans Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Marksans Pharma Ltd. is 26.6, and the Price-to-Book (PB) ratio is 3.4.

What is the 52-Week High and Low for Marksans Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Marksans Pharma Ltd. shares was ₹ 270.7, and the lowest price was ₹ 155.

What is the current dividend yield for Marksans Pharma Ltd.?

As of 6 June 2025, the dividend yield for Marksans Pharma Ltd. is 0.4%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Marksans Pharma Ltd.?

Significant shareholdings in Marksans Pharma Ltd. typically include entities such as:

Promoter
Public
FII
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Marksans Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Marksans Pharma Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Marksans Pharma Ltd.?

Marksans Pharma Ltd. last declared a FINAL dividend of ₹ 0.8 per share for the financial period ending 2025. The record date was set as 2025-08-01, and the payment was/is scheduled around 2025-08-01. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy